GlassScriptPhysician profile
William A Huang
NPI 1144457029
$13,520.72
in general payments reported to CMS, 2019-2025
44 companies · $2,182 in 2025
The $2,182 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,453 · 2020: $839 · 2021: $1,518 · 2022: $2,047 · 2023: $2,062 · 2024: $2,419 · 2025: $2,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,593 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,593.08 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,121.25 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,494.80 | 2019-2025 | Lifevest |
| Abbott Laboratories | $1,473.01 | 2019-2025 | Tacticath Ablation Catheter, Sensor Enabled, Aveir, Gallant |
| Astrazeneca Pharmaceuticals LP | $741.31 | 2019-2025 | Farxiga, Brilinta |
| Merck Sharp & Dohme LLC | $712.50 | 2021-2025 | Verquvo, Capvaxive |
| Boston Scientific Corporation | $679.29 | 2019-2025 | Bodyguardian, General - Therapies, Resonate El Icd Vr |
| E.R. Squibb & Sons, L.L.C. | $625.35 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $501.22 | 2019-2023 | Xarelto |
| Medtronic Vascular, INC. | $497.24 | 2019-2020 | |
| Novo Nordisk INC | $476.15 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $470.49 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $398.56 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $396.96 | 2019-2025 | Jardiance |
| Impulse Dynamics (USA) INC. | $285.38 | 2022-2025 | Optimizer, Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $257.25 | 2021-2023 | Arcalyst |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $249.25 | 2019-2024 | |
| Lexicon Pharmaceuticals, INC. | $242.88 | 2023-2024 | Inpefa |
| Medtronic, INC. | $228.79 | 2021-2023 | Selectsecure, Micra, Corevalve Evolut R |
| Kestra Medical Technology Services, INC. | $197.68 | 2022-2025 | Assure Wcd |
| Atricure, INC. | $165.15 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Cardiva Medical, INC. | $117.27 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Kiniksa Pharmaceuticals International, Plc | $107.55 | 2024 | Arcalyst |
| Baxter Healthcare | $106.88 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Irhythm Technologies, INC. | $106.78 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Biotronik INC. | $96.73 | 2021-2024 | Biomonitor |
| Esperion Therapeutics, INC. | $95.98 | 2021-2025 | Nexletol |
| Altathera Pharmaceuticals LLC | $74.88 | 2025 | Sotalol Hydrochloride |
| Alnylam Pharmaceuticals INC. | $74.14 | 2024 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $68.97 | 2022-2025 | |
| Heartflow, INC. | $58.91 | 2024-2025 | |
| Biosense Webster, INC. | $53.19 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $39.70 | 2022-2023 | Uptravi, Opsumit |
| Philips North America LLC | $38.64 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $33.15 | 2021 | |
| Abiomed | $30.66 | 2021 | |
| United Therapeutics Corporation | $30.08 | 2024 | |
| Ionis Pharmaceuticals, INC. | $29.60 | 2025 | Tryngolza |
| Angiodynamics, INC. | $26.68 | 2019 | |
| Ge Healthcare | $25.36 | 2022 | |
| Cvrx, INC. | $22.58 | 2021 | |
| Aegerion Pharmaceuticals, INC. | $19.94 | 2019 | |
| Glaxosmithkline, LLC. | $19.07 | 2025 | Arexvy, Shingrix |
| Scpharmaceuticals INC. | $17.00 | 2023 | |
| Vivaquant INC, Dba Rhythm Express | $12.47 | 2024 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.